PALO ALTO, Calif.--(BUSINESS WIRE)--twoXAR, Inc., a company dedicated to improving health through computation, today announced that it has been named as one of the inaugural MIT Startup Exchange (STEX) STEX25 companies. STEX25 is a select group of industry-ready startups that are actively promoted to members of the MIT Industrial Liaison Program (ILP). The ILP was established in 1948 to foster mutually beneficial relationships between MIT and corporations worldwide.
“The MIT community was instrumental in the founding of twoXAR and has remained a valuable resource for us as we’ve grown the company,” said MIT alumnus Andrew M. Radin, co-founder and Chief Marketing Officer at twoXAR. “We are honored to be part of this distinguished group of startups and look forward to working with corporate members of the MIT ILP.”
MIT Startup Exchange, a program of the MIT Office of Corporate Relations, facilitates introductions between MIT’s ILP corporations and MIT-connected startups. In 2016, STEX made over 500 initial introductions between ILP members and startups. These introductions led to partnerships, licensed technology, customer agreements and other commercial arrangements. 1,200+ startups are part of STEX from across all research centers and departments at MIT. Collectively, STEX startups are shaping the future across existing and emerging industries. STEX25 is a startup accelerator focused on accelerating partnerships between STEX startups and ILP member corporations. Twenty-five of the most promising STEX startups are selected to participate in the 12-month accelerator. STEX25 startups receive additional promotion, prominent exposure at STEX workshops and ILP conferences, and matchmaking services with ILP members. STEX25 is organized and run by the MIT Startup Exchange.
"We’re very pleased to name twoXAR as part of STEX25,” said Trond Undheim, who directs the MIT Startup Exchange. “STEX25 companies have a strong science and technology foundation, typically exhibit strong growth, and are relevant innovation partners for a wide variety of multinational companies where we make active introductions at the right levels in the organization."
For more information please visit http://startupexchange.mit.edu.
twoXAR is an artificial intelligence-driven biopharmaceutical company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry partnerships. Based in Palo Alto, California, the twoXAR team includes experts in drug discovery and development, biomedical informatics, computational biology, data science, and software development. For more information, please visit www.twoXAR.com.